These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32508359)

  • 1. Impact of Pharmacist-Led Procalcitonin-Guided Antibiotic Therapy in Critically Ill Patients With Pneumonia.
    Subedi B; Louzon P; Zappas K; Onyia W; DeBoer K
    Hosp Pharm; 2020 Jun; 55(3):204-210. PubMed ID: 32508359
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of Pharmacist-Directed Simplified Procalcitonin Algorithm on Antibiotic Therapy in Critically Ill Patients With Sepsis.
    Willmon J; Subedi B; Girgis R; Noe M
    Hosp Pharm; 2021 Oct; 56(5):501-506. PubMed ID: 34720152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ineffectiveness of procalcitonin-guided antibiotic therapy in severely critically ill patients: A meta-analysis.
    Peng F; Chang W; Xie JF; Sun Q; Qiu HB; Yang Y
    Int J Infect Dis; 2019 Aug; 85():158-166. PubMed ID: 31229612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin-Guided Antibiotic Therapy Reduces Antibiotic Use for Lower Respiratory Tract Infections in a United States Medical Center: Results of a Clinical Trial.
    Townsend J; Adams V; Galiatsatos P; Pearse D; Pantle H; Masterson M; Kisuule F; Jacob E; Kiruthi C; Ortiz P; Agbanlog A; Jurao R; Stern S; Nayak S; Melgar M; Sama J; Irwin J; Mazidi C; Psoter K; McKenzie R
    Open Forum Infect Dis; 2018 Dec; 5(12):ofy327. PubMed ID: 30619913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of procalcitonin guidance in reducing the duration of antibiotic treatment in critically ill patients: a randomised, controlled, open-label trial.
    de Jong E; van Oers JA; Beishuizen A; Vos P; Vermeijden WJ; Haas LE; Loef BG; Dormans T; van Melsen GC; Kluiters YC; Kemperman H; van den Elsen MJ; Schouten JA; Streefkerk JO; Krabbe HG; Kieft H; Kluge GH; van Dam VC; van Pelt J; Bormans L; Otten MB; Reidinga AC; Endeman H; Twisk JW; van de Garde EMW; de Smet AMGA; Kesecioglu J; Girbes AR; Nijsten MW; de Lange DW
    Lancet Infect Dis; 2016 Jul; 16(7):819-827. PubMed ID: 26947523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procalcitonin-Guided Antibiotic Discontinuation Might Shorten the Duration of Antibiotic Treatment Without Increasing Pneumonia Recurrence.
    Akagi T; Nagata N; Wakamatsu K; Harada T; Miyazaki H; Takeda S; Ushijima S; Aoyama T; Yoshida Y; Yatsugi H; Wada K; Ueda Y; Fujita M; Watanabe K
    Am J Med Sci; 2019 Jul; 358(1):33-44. PubMed ID: 31084909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study.
    Daubin C; Valette X; Thiollière F; Mira JP; Hazera P; Annane D; Labbe V; Floccard B; Fournel F; Terzi N; Du Cheyron D; Parienti JJ;
    Intensive Care Med; 2018 Apr; 44(4):428-437. PubMed ID: 29663044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact on antimicrobial consumption of procalcitonin-guided antibiotic therapy for pneumonia/pneumonitis associated with aspiration in comatose mechanically ventilated patients: a multicenter, randomized controlled study.
    Labro G; Aptel F; Puyraveau M; Paillot J; Pili Floury S; Merdji H; Helms J; Piton G; Ecarnot F; Kuteifan K; Quenot JP; Capellier G;
    Ann Intensive Care; 2021 Oct; 11(1):145. PubMed ID: 34636974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Comparison of Procalcitonin Guidance Administer Antibiotics with Empiric Antibiotic Therapy in Critically Ill Patients Admitted in Intensive Care Unit.
    Najafi A; Khodadadian A; Sanatkar M; Shariat Moharari R; Etezadi F; Ahmadi A; Imani F; Khajavi MR
    Acta Med Iran; 2015; 53(9):562-7. PubMed ID: 26553084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Procalcitonin-Guided Treatment on Duration of Antibiotic Therapy and Cost in Septic Patients (PRODA): a Multi-Center Randomized Controlled Trial.
    Jeon K; Suh JK; Jang EJ; Cho S; Ryu HG; Na S; Hong SB; Lee HJ; Kim JY; Lee SM
    J Korean Med Sci; 2019 Apr; 34(14):e110. PubMed ID: 30977312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Procalcitonin Monitoring on Duration of Antibiotics in Patients With Sepsis and/or Pneumonia in a Community Hospital Setting.
    Covington EW; Eure S; Carroll D; Freeman C
    J Pharm Technol; 2018 Jun; 34(3):109-116. PubMed ID: 34861025
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of introducing procalcitonin on antimicrobial therapy duration in patients with sepsis and/or pneumonia in the intensive care unit.
    Bishop BM; Bon JJ; Trienski TL; Pasquale TR; Martin BR; File TM
    Ann Pharmacother; 2014 May; 48(5):577-83. PubMed ID: 24519479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness of procalcitonin-guided antibiotic therapy to shorten treatment duration in critically-ill patients with bloodstream infections: a systematic review and meta-analysis.
    Robati Anaraki M; Nouri-Vaskeh M; Abdoli Oskouie S
    Infez Med; 2020 Mar; 28(1):37-46. PubMed ID: 32172259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of Procalcitonin's Utility to Predict Concomitant Bacterial Pneumonia in Critically Ill COVID-19 Patients.
    Patel N; Adams C; Brunetti L; Bargoud C; Teichman AL; Choron RL
    J Intensive Care Med; 2022 Nov; 37(11):1486-1492. PubMed ID: 35711161
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation of Serial Procalcitonin Levels for the Optimization of Antibiotic Use in Non-Critically Ill COVID-19 Patients.
    Almulhim AS; Alabdulwahed MA; Aldoughan FF; Aldayyen AM; Alghamdi F; Alabdulqader R; Alnaim N; Alghannam D; Aljamaan Y; Almutairi S; Al Mogbel FT; Alamer A; Wali HA
    Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Procalcitonin Guidance on Management of Adults Hospitalized with Chronic Obstructive Pulmonary Disease Exacerbations.
    Bremmer DN; DiSilvio BE; Hammer C; Beg M; Vishwanathan S; Speredelozzi D; Moffa MA; Hu K; Abdulmassih R; Makadia JT; Sandhu R; Naddour M; Chan-Tompkins NH; Trienski TL; Watson C; Obringer TJ; Kuzyck J; Walsh TL
    J Gen Intern Med; 2018 May; 33(5):692-697. PubMed ID: 29404940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin-Guided Antibiotic Discontinuation and Mortality in Critically Ill Adults: A Systematic Review and Meta-analysis.
    Pepper DJ; Sun J; Rhee C; Welsh J; Powers JH; Danner RL; Kadri SS
    Chest; 2019 Jun; 155(6):1109-1118. PubMed ID: 30772386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Procalcitonin-guided antibiotic therapy in critically ill adults: a meta-analysis.
    Zhang T; Wang Y; Yang Q; Dong Y
    BMC Infect Dis; 2017 Jul; 17(1):514. PubMed ID: 28738787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Procalcitonin-guided antibiotic therapy may shorten length of treatment and may improve survival-a systematic review and meta-analysis.
    Papp M; Kiss N; Baka M; Trásy D; Zubek L; Fehérvári P; Harnos A; Turan C; Hegyi P; Molnár Z
    Crit Care; 2023 Oct; 27(1):394. PubMed ID: 37833778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Procalcitonin algorithm in critically ill adults with undifferentiated infection or suspected sepsis. A randomized controlled trial.
    Shehabi Y; Sterba M; Garrett PM; Rachakonda KS; Stephens D; Harrigan P; Walker A; Bailey MJ; Johnson B; Millis D; Ding G; Peake S; Wong H; Thomas J; Smith K; Forbes L; Hardie M; Micallef S; Fraser JF; ;
    Am J Respir Crit Care Med; 2014 Nov; 190(10):1102-10. PubMed ID: 25295709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.